Advertisement - Members don't see this ad
There are currently two PGY-2 Pharmacogenomics programs (Shands and St. Jude), does anyone think these will become more commonplace in the near future? Considering the possibility of implementing practical/affordable pharmacogenetic testing in the future this could be an interesting way to go.